SINAGRA, GIANFRANCO
 Distribuzione geografica
Continente #
EU - Europa 585
NA - Nord America 426
AS - Asia 243
OC - Oceania 2
SA - Sud America 2
Totale 1.258
Nazione #
US - Stati Uniti d'America 401
IT - Italia 244
SG - Singapore 164
DE - Germania 98
IE - Irlanda 67
RU - Federazione Russa 52
GB - Regno Unito 49
CN - Cina 33
CA - Canada 24
VN - Vietnam 18
UA - Ucraina 15
FI - Finlandia 14
SE - Svezia 14
PK - Pakistan 11
BE - Belgio 10
NL - Olanda 8
IN - India 7
LT - Lituania 6
CH - Svizzera 5
HK - Hong Kong 4
AT - Austria 3
BD - Bangladesh 2
BR - Brasile 2
NZ - Nuova Zelanda 2
IR - Iran 1
JP - Giappone 1
KZ - Kazakistan 1
MX - Messico 1
TR - Turchia 1
Totale 1.258
Città #
Singapore 138
Dublin 67
Chandler 60
Milan 30
Munich 30
San Mateo 30
Boardman 29
Ottawa 23
Fairfield 22
Cambridge 20
Santa Clara 17
West Jordan 16
Rome 15
London 14
Portsmouth 14
Stevenage 14
Krefeld 13
Pisa 13
Wilmington 13
Ashburn 12
Bologna 11
Lawrence 11
Bad Bellingen 10
Dong Ket 10
Helsinki 10
Houston 10
Seattle 10
Brussels 8
Frankfurt am Main 8
Livorno 8
Beijing 7
Florence 7
Genoa 7
New Delhi 7
Nuremberg 7
Assago 6
Mykolayiv 6
San Diego 6
Veglie 6
Woodbridge 6
Azzano San Paolo 5
Brescia 5
Washington 5
Brooklyn 4
Central District 4
Lappeenranta 4
Bari 3
Castelliri 3
Palermo 3
Parma 3
Peshawar 3
Shanghai 3
Vienna 3
Amandola 2
Ann Arbor 2
Auckland 2
Baronissi 2
Bioggio 2
Brembate di Sopra 2
Bussolengo 2
Catania 2
Costa Volpino 2
Ferrara 2
Fremont 2
Gozzano 2
Hanover 2
Lahore 2
Laurel 2
Lausanne 2
Multan 2
Naples 2
Nicosia 2
San Mauro Pascoli 2
Scuola 2
Taranto 2
Albavilla 1
Altopascio 1
Amsterdam 1
Belo Horizonte 1
Cagliari 1
Caltanissetta 1
Cambiago 1
Camden 1
Cascina 1
Cecina 1
Contagem 1
Dallas 1
Desenzano del Garda 1
Forlì 1
Fuzhou 1
Gothenburg 1
Guangzhou 1
Hamburg 1
Handan 1
Hounslow 1
Islington 1
Karaganda 1
Kilburn 1
Los Angeles 1
Mainz 1
Totale 868
Nome #
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 162
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 89
Exploring the Prognostic Performance of MECKI Score in Heart Failure Patients with Non-Valvular Atrial Fibrillation Treated with Edoxaban 83
Roles of periodic breathing and isocapnic buffering period during exercise in heart failure 75
Cardiovascular Death Risk in Recovered Mid-Range Ejection Fraction Heart Failure: Insights From Cardiopulmonary Exercise Test 59
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 59
Increased serum uric acid level predicts poor prognosis in mildly severe chronic heart failure with reduced ejection fraction. An analysis from the MECKI score research group 56
Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy 54
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension 52
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction 51
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies 44
Inferior Vena Cava Edge Tracking Echocardiography: A Promising Tool with Applications in Multiple Clinical Settings 44
Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score 42
Global Right Heart Assessment with Speckle-Tracking Imaging Improves the Risk Prediction of a Validated Scoring System in Pulmonary Arterial Hypertension 40
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 38
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 31
Valvular heart disease in patients with cardiac amyloidosis 30
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 30
Association between implantable defibrillator-detected sleep apnea and atrial fibrillation: The DASAP-HF study 29
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 26
Heart failure patients with improved ejection fraction: Insights from the MECKI score database 25
Sex differences in the prognostic role of achieving target doses of heart failure medications: Data from the Swedish Heart Failure Registry 25
[Ten perspectives for research and innovation in cardiac amyloidosis] 25
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 21
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study 21
Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension 19
[Transcatheter devices for chronic heart failure: state of the art] 18
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set 16
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 11
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 11
Pressure-volume relationship by pharmacological stress cardiovascular magnetic resonance 11
Early diagnosis, disease stage and prognosis in wild‐type transthyretin amyloid cardiomyopathy: The DIAMOND study 10
Tafamidis in the Treatment of ATTR-related Cardiomyopathy 8
Totale 1.315
Categoria #
all - tutte 14.300
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.300


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021101 0 0 0 0 0 0 0 0 48 5 30 18
2021/2022174 19 25 2 19 0 6 19 25 10 28 7 14
2022/2023204 12 21 3 15 22 23 5 23 52 1 17 10
2023/2024332 10 7 39 23 5 16 13 27 43 33 33 83
2024/2025504 31 81 137 52 112 90 1 0 0 0 0 0
Totale 1.315